CAMP Projects

Find out more about our Projects here!

Projects within CAMP are operated within three work packages (WP1-3) covering scientific and technological challenges and infrastructure around process development and production of ATMP.

Twelve collaboration projects engaging partners from healthcare, industry and academy have been started within WP1-3. More projects are under planning and expected to start during 2020.

The current project portfolio consists of the following:

WP1 – Process development

Work package leader – Stefan Scheding

– Label-free sorting of stromal cell preparations for clinical use

– ATMP for urethra reconstruction with de- and recellularization technique

– Development of Multilayered Tissue-Engineered Skin Construct

– GMP production of pluripotent stem cells and its derivatives.

– Development of producer lines for delivering therapeutic mRNAs through Extracellular Vesicles.

– CAR-T cell therapy for malignant melanoma of the skin and the eye.

– Value survey – How do donors, patients, the general public and policy makers want to balance different interests?

WP2 – Infrastructure for GMP manufacturing

Work package leader – Pontus Blomberg

– Developing a Pre-GMP facility for vectors and genetically modified cells

– Vecura – An Infrastructure for Development and Manufacturing of ATMPs

– Expansion of GMP Compliant – Tumor Infiltrating Lymphocytes (TILs) in Xuri bioreactor

– Harmonizing HQ plasmid production between pre-GMP and GMP sites

WP3 – Quality control, shelf-life and logistics

Work package leader – Jim Lund

– Establishing a QC and logistics strategy of cell-based products for secure patient treatment

– Single cell qPCR characterization of ATMP

– Establishing a non-dry ice dependent logistics strategy for cell therapies.

For more information, with new ideas or to get involved please contact:

Jukka Lausmaa – Centre Director email
Pontus Blomberg – Scientific director email